dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Oaknin Benzaquen, Ana Mazaltob |
dc.contributor.author | Friedman, Claire F. |
dc.contributor.author | Roman, Lynda D. |
dc.contributor.author | D'Souza, Anishka |
dc.contributor.author | Braña Garcia, Irene |
dc.contributor.author | Bidard, François-Clement |
dc.date.accessioned | 2021-09-21T10:47:42Z |
dc.date.available | 2021-09-21T10:47:42Z |
dc.date.issued | 2020-10 |
dc.identifier.citation | Oaknin A, Friedman CF, Roman LD, D'Souza A, Brana I, Bidard FC, et al. Neratinib in patients with HER2-mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial. Gynecol Oncol. 2020 Oct;159:150–6. |
dc.identifier.issn | 0090-8258 |
dc.identifier.uri | https://hdl.handle.net/11351/6338 |
dc.description | Càncer de coll uterí; Assaig clínic; Mutant HER2 |
dc.description.sponsorship | This work was supported by Puma Biotechnology Inc . 10880 Wilshire Blvd, Suite 2150, Los Angeles, CA 90024, USA. |
dc.language.iso | eng |
dc.publisher | Elsevier |
dc.relation.ispartofseries | Gynecologic Oncology;159 |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Coll uterí - Càncer - Tractament |
dc.subject | Proteïnes quinases - Inhibidors |
dc.subject.mesh | Uterine Cervical Neoplasms |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Protein Kinase Inhibitors |
dc.title | Neratinib in patients with HER2 -mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1016/j.ygyno.2020.07.025 |
dc.subject.decs | neoplasias del cuello uterino |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | inhibidores de proteínas cinasas |
dc.relation.publishversion | https://doi.org/10.1016/j.ygyno.2020.07.025 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Oaknin A, Brana I] Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Friedman CF] Memorial Sloan Kettering Cancer Center, New York, NY, USA. [Roman LD, D'Souza A] USC Norris Comprehensive Cancer Center, Los Angeles, CA, USA. [Bidard FC] Institut Curie, St Cloud, France |
dc.identifier.pmid | 32723675 |
dc.identifier.wos | 000576604900023 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |